Cargando…
A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity
QXOH, a QX314 derivative with longer duration and lesser local toxicity, is a novel local anesthetic in preclinical drug development. Previous studies demonstrated that bupivacaine can prolong the effects of QX314. So, we attempted to combine QXOH with levobupivacaine to shorten the onset time and l...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443723/ https://www.ncbi.nlm.nih.gov/pubmed/30971919 http://dx.doi.org/10.3389/fphar.2019.00243 |
_version_ | 1783407888444686336 |
---|---|
author | Yin, Qinqin Zhang, Yujun Lv, Rong Gong, Deying Ke, Bowen Yang, Jun Tang, Lei Zhang, Wensheng Zhu, Tao |
author_facet | Yin, Qinqin Zhang, Yujun Lv, Rong Gong, Deying Ke, Bowen Yang, Jun Tang, Lei Zhang, Wensheng Zhu, Tao |
author_sort | Yin, Qinqin |
collection | PubMed |
description | QXOH, a QX314 derivative with longer duration and lesser local toxicity, is a novel local anesthetic in preclinical drug development. Previous studies demonstrated that bupivacaine can prolong the effects of QX314. So, we attempted to combine QXOH with levobupivacaine to shorten the onset time and lengthen the duration. In this study, we investigated the efficacy, local and systemic toxicity in rats. In subcutaneous infiltration anesthesia, the inhibition of cutaneous trunci muscle reflex for QXOH-LB was greater than QXOH and levobupivacaine in the first 8 h (QXOH-LB vs. QXOH, P = 0.004; QXOH-LB vs. LB, P = 0.004). The completely recovery time for QXOH-LB (17.5 ± 2.5 h) was significantly longer than levobupivacaine (9.0 ± 1.3 h, P = 0.034) and QXOH (9.8 ± 0.9 h, P = 0.049). In sciatic nerve block, QXOH-LB produced a rapid onset time, which was obviously shorter than QXOH. For sensory, the time to recovery for QXOH-LB was 17.3 ± 2.6 h, which was statistically longer than 6.0 ± 1.8 h for QXOH (P = 0.027), and 4 h for levobupivacaine (P = 0.001). Meanwhile, the time to motor recovery for QXOH-LB was 7.9 ± 2.8 h, significantly longer than 4 h for levobupivacaine (P = 0.003) but similar to 6.0 ± 1.7 h for QXOH (P = 0.061). In local toxicity, there was no significant difference of histological score regarding muscle and sciatic nerve in QXOH-LB, QXOH, levobupivacaine and saline (P < 0.01). In the combination, the interaction index of LD(50) was 1.39, indicating antagonistic interaction between QXOH and levobupivacaine in terms of systemic toxicity. In this study, we demonstrated that QXOH-LB produced cutaneous anesthesia which was 2-fold greater than that produced by QXOH or LB alone, and elicited sciatic nerve block with a potency that was 5- and 3-fold that of LB and QXOH, respectively. Local tissue inflammation by QXOH-LB was mild, similar to that induced by LB. This fixed-dose combination led to an antagonistic interaction between QXOH and LB in terms of systemic toxicity. These results suggested that QXOH-LB induced a long-lasting local anesthesia, likely, avoiding clinically important local and systemic toxicities. |
format | Online Article Text |
id | pubmed-6443723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64437232019-04-10 A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity Yin, Qinqin Zhang, Yujun Lv, Rong Gong, Deying Ke, Bowen Yang, Jun Tang, Lei Zhang, Wensheng Zhu, Tao Front Pharmacol Pharmacology QXOH, a QX314 derivative with longer duration and lesser local toxicity, is a novel local anesthetic in preclinical drug development. Previous studies demonstrated that bupivacaine can prolong the effects of QX314. So, we attempted to combine QXOH with levobupivacaine to shorten the onset time and lengthen the duration. In this study, we investigated the efficacy, local and systemic toxicity in rats. In subcutaneous infiltration anesthesia, the inhibition of cutaneous trunci muscle reflex for QXOH-LB was greater than QXOH and levobupivacaine in the first 8 h (QXOH-LB vs. QXOH, P = 0.004; QXOH-LB vs. LB, P = 0.004). The completely recovery time for QXOH-LB (17.5 ± 2.5 h) was significantly longer than levobupivacaine (9.0 ± 1.3 h, P = 0.034) and QXOH (9.8 ± 0.9 h, P = 0.049). In sciatic nerve block, QXOH-LB produced a rapid onset time, which was obviously shorter than QXOH. For sensory, the time to recovery for QXOH-LB was 17.3 ± 2.6 h, which was statistically longer than 6.0 ± 1.8 h for QXOH (P = 0.027), and 4 h for levobupivacaine (P = 0.001). Meanwhile, the time to motor recovery for QXOH-LB was 7.9 ± 2.8 h, significantly longer than 4 h for levobupivacaine (P = 0.003) but similar to 6.0 ± 1.7 h for QXOH (P = 0.061). In local toxicity, there was no significant difference of histological score regarding muscle and sciatic nerve in QXOH-LB, QXOH, levobupivacaine and saline (P < 0.01). In the combination, the interaction index of LD(50) was 1.39, indicating antagonistic interaction between QXOH and levobupivacaine in terms of systemic toxicity. In this study, we demonstrated that QXOH-LB produced cutaneous anesthesia which was 2-fold greater than that produced by QXOH or LB alone, and elicited sciatic nerve block with a potency that was 5- and 3-fold that of LB and QXOH, respectively. Local tissue inflammation by QXOH-LB was mild, similar to that induced by LB. This fixed-dose combination led to an antagonistic interaction between QXOH and LB in terms of systemic toxicity. These results suggested that QXOH-LB induced a long-lasting local anesthesia, likely, avoiding clinically important local and systemic toxicities. Frontiers Media S.A. 2019-03-26 /pmc/articles/PMC6443723/ /pubmed/30971919 http://dx.doi.org/10.3389/fphar.2019.00243 Text en Copyright © 2019 Yin, Zhang, Lv, Gong, Ke, Yang, Tang, Zhang and Zhu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Yin, Qinqin Zhang, Yujun Lv, Rong Gong, Deying Ke, Bowen Yang, Jun Tang, Lei Zhang, Wensheng Zhu, Tao A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity |
title | A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity |
title_full | A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity |
title_fullStr | A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity |
title_full_unstemmed | A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity |
title_short | A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity |
title_sort | fixed-dose combination, qxoh/levobupivacaine, produces long-acting local anesthesia in rats without additional toxicity |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443723/ https://www.ncbi.nlm.nih.gov/pubmed/30971919 http://dx.doi.org/10.3389/fphar.2019.00243 |
work_keys_str_mv | AT yinqinqin afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT zhangyujun afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT lvrong afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT gongdeying afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT kebowen afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT yangjun afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT tanglei afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT zhangwensheng afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT zhutao afixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT yinqinqin fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT zhangyujun fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT lvrong fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT gongdeying fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT kebowen fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT yangjun fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT tanglei fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT zhangwensheng fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity AT zhutao fixeddosecombinationqxohlevobupivacaineproduceslongactinglocalanesthesiainratswithoutadditionaltoxicity |